Vincent Cutrona Sells Shares of CHMG
Vincent Cutrona, EVP & President-Canal Bank Div at CHMG, sold 98 shares on June 24, 2026.
Key Points
- Vincent Cutrona sold 98 shares of CHMG at $74.4 each on June 24, 2026, for a total of $7,291.20.
- Shares of CHMG traded near $74.4 on Thursday, with a 52-week range of N/A.
- BlackRock reduced its CHMG holdings by 6,766 shares, while Vanguard Capital Management opened a new position.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Vincent Cutrona, the Executive Vice President and President of the Canal Bank Division at CHMG, sold 98 shares of the company on June 24, 2026. The shares were sold at an average price of $74.4, bringing the total transaction value to $7,291.20. This transaction was not part of a pre-arranged trading plan.
Other Institutional Activity in CHMG
BlackRock, Inc. reduced its holdings in CHMG by 6,766 shares, bringing its total to 361,827 shares valued at approximately $19.47 million. Chemung Canal Trust Co also trimmed its position slightly by 74 shares, ending with 286,152 shares worth around $15.40 million. Dimensional Fund Advisors LP increased its stake by 2,172 shares to a total of 181,841 shares, valued at about $9.79 million. Vanguard Capital Management LLC opened a new position with 173,244 shares, valued at approximately $9.32 million. Meanwhile, Manufacturers Life Insurance Company added 18,171 shares, raising its holdings by 13% to 157,633 shares, worth about $8.48 million.
Chemung Financial Corporation Stock Down 8.8%
Shares of CHMG traded near $74.4 on Thursday. The company has a 52-week low and high that were not provided. The stock's performance metrics, such as market cap, P/E ratio, and beta, were not available.
$CHMG stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Chemung Financial Corporation
On June 24, 2026, Vincent Cutrona sold 98 shares of CHMG at $74.4 each, totaling $7,291.20. Earlier in the year, on April 27, 2026, Thomas Tyrrell sold 788 shares at an average price of $65.33. On February 27, 2026, several insiders, including Kimberly Hazelton, Loren Cole, and Mary Meisner, sold shares at $55.52 each.
Analysts Set New Price Targets
On January 28, 2026, Keefe, Bruyette & Woods maintained its hold rating on CHMG with a price target of $64. Piper Sandler has consistently held a hold rating, most recently setting a target of $50 on April 22, 2025. Analysts' consensus indicates a hold recommendation with a mean target price not disclosed.
About CHMG
CHMG is involved in financial services, offering a range of banking products and services. The company operates through various divisions, including the Canal Bank Division, providing personal and business banking solutions. The company is based in the United States.
Bottom Line
Vincent Cutrona's recent sale of CHMG shares is a notable transaction for investors following insider activity. While the sale may not indicate any specific outlook, it adds to the narrative of insider trading patterns at the company. As always, insider transactions are backward-looking and provide a glimpse into past actions rather than current intentions.
Get Chemung Financial Corporation alerts
New 13F filings, insider trades, and analyst moves on $CHMG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
